INCOBOTULINUMTOXINA

INCOBOTULINUMTOXINA was reported 5818 times

INCOBOTULINUMTOXINA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INJECTION SITE MUSCLE WEAKNESS 9 0.1875
1 PARAOESOPHAGEAL ABSCESS 1 0.1667
2 PARADOXICAL MASSETER MUSCLE BULGING 1 0.1000
3 MEPHISTO SIGN 5 0.0704
4 INJECTION SITE GRANULOMA 16 0.0675
5 INJECTION SITE DEFORMATION 6 0.0674
6 BROW PTOSIS 43 0.0655
7 INJECTION SITE MUSCLE ATROPHY 2 0.0625
8 PERIORBITAL FAT HERNIATION 1 0.0588
9 ORAL SUBMUCOSAL FIBROSIS 1 0.0526
10 EYELID DERMATOCHALASIS 1 0.0455
11 NEUROLOGICAL EYELID DISORDER 1 0.0417
12 BOTULISM 30 0.0362
13 PRODUCT PREPARATION ISSUE 216 0.0329
14 CRANIAL NERVE INFECTION 1 0.0312
15 GLOSSOPHARYNGEAL NERVE DISORDER 1 0.0256
16 CORTICAL LAMINAR NECROSIS 1 0.0250
17 CSF IMMUNOGLOBULIN INCREASED 1 0.0244
18 NEUTRALISING ANTIBODIES 3 0.0238
19 VESSEL PERFORATION 3 0.0227
20 FACIAL ASYMMETRY 17 0.0178
21 HYPOZINCAEMIA 1 0.0169
22 INJECTION SITE MOVEMENT IMPAIRMENT 2 0.0156
23 INJECTION SITE HYPERSENSITIVITY 47 0.0150
24 INJECTION SITE OEDEMA 25 0.0145
25 OBSESSIVE RUMINATION 1 0.0143
26 INJECTION SITE ISCHAEMIA 1 0.0139
27 DERMATOCHALASIS 2 0.0136
28 EYELID PTOSIS 134 0.0132
29 THERAPEUTIC RESPONSE DECREASED 761 0.0125
30 PHYLLODES TUMOUR 1 0.0123
31 PITYRIASIS LICHENOIDES ET VARIOLIFORMIS ACUTA 1 0.0123
32 IATROGENIC INFECTION 1 0.0122
33 MYCOTIC ANEURYSM 1 0.0119
34 HEMIANOPIA HETERONYMOUS 1 0.0116
35 COELIAC ARTERY STENOSIS 1 0.0110
36 LID SULCUS DEEPENED 4 0.0107
37 INTRANASAL HYPOAESTHESIA 1 0.0106
38 INJECTION SITE PARAESTHESIA 16 0.0104
39 ADMINISTRATION RELATED REACTION 2 0.0103
40 MANUFACTURING PRODUCT SHIPPING ISSUE 5 0.0092
41 HISTAMINE INTOLERANCE 2 0.0088
42 INJECTION SITE FIBROSIS 1 0.0085
43 INJECTION SITE HYPOAESTHESIA 12 0.0084
44 OESOPHAGEAL MOTILITY DISORDER 3 0.0083
45 PHARYNGEAL HAEMATOMA 1 0.0083
46 MEDICAL DEVICE SITE ERYTHEMA 1 0.0078
47 HYPOAESTHESIA TEETH 1 0.0078
48 LARYNGITIS FUNGAL 1 0.0078
49 BURN OF INTERNAL ORGANS 1 0.0072
50 SUSPECTED PRODUCT QUALITY ISSUE 13 0.0071
51 OCCIPITAL NEURALGIA 4 0.0071
52 B-LYMPHOCYTE ABNORMALITIES 1 0.0070
53 INJECTION SITE DERMATITIS 1 0.0069
54 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 115 0.0067
55 LYMPHATIC DISORDER 4 0.0067
56 DIAPHRAGM MUSCLE WEAKNESS 1 0.0063
57 ANTINUCLEAR ANTIBODY 1 0.0063
58 INJECTION SITE PALLOR 2 0.0063
59 EXTRAOCULAR MUSCLE DISORDER 2 0.0062
60 BLOOD IMMUNOGLOBULIN A DECREASED 4 0.0061
61 LARYNGEAL OBSTRUCTION 1 0.0055
62 APPLICATION SITE HAEMATOMA 1 0.0055
63 INJECTION SITE PUSTULE 2 0.0052
64 INJECTION SITE ECZEMA 1 0.0052
65 ANAEMIA FOLATE DEFICIENCY 1 0.0052
66 MEDIASTINITIS 3 0.0052
67 INJECTION SITE INDENTATION 11 0.0051
68 IRREGULAR SLEEP WAKE RHYTHM DISORDER 1 0.0050
69 EXPOSURE VIA EYE CONTACT 2 0.0048
70 GENITAL HERPES SIMPLEX 1 0.0047
71 ADULT FAILURE TO THRIVE 1 0.0047
72 IMMOBILISATION SYNDROME 1 0.0047
73 INJECTION SITE INFLAMMATION 23 0.0046
74 MITE ALLERGY 3 0.0046
75 CENTRAL VISION LOSS 1 0.0045
76 MILLER FISHER SYNDROME 1 0.0045
77 EXTRAOCULAR MUSCLE PARESIS 2 0.0044
78 SKIN INDENTATION 2 0.0042
79 IVTH NERVE PARALYSIS 1 0.0042
80 INJECTION SITE NERVE DAMAGE 1 0.0042
81 NEUROGENIC BOWEL 1 0.0042
82 MENSTRUAL CLOTS 1 0.0042
83 MOTOR NEURONE DISEASE 2 0.0041
84 SKIN WRINKLING 11 0.0040
85 INDURATION 7 0.0039
86 EYELID DISORDER 9 0.0039
87 MASS 54 0.0039
88 EYELID FUNCTION DISORDER 3 0.0038
89 EYE COMPLICATION ASSOCIATED WITH DEVICE 1 0.0037
90 TENDERNESS 38 0.0036
91 INJECTION SITE MASS 134 0.0036
92 ORTHOSIS USER 1 0.0036
93 EYELID THICKENING 1 0.0035
94 ALLERGIC SINUSITIS 3 0.0035
95 INJECTION SITE CYST 1 0.0034
96 IRREGULAR BREATHING 2 0.0034
97 ENDOTRACHEAL INTUBATION COMPLICATION 2 0.0034
98 NUCHAL RIGIDITY 3 0.0033
99 INCISION SITE SWELLING 1 0.0033
100 PUPILLARY DISORDER 2 0.0033
101 ALLERGY TO ARTHROPOD BITE 1 0.0031
102 INJECTION SITE HYPERTROPHY 1 0.0031
103 DUST ALLERGY 3 0.0031
104 INJECTION SITE INFECTION 10 0.0030
105 BREAST HAEMORRHAGE 1 0.0030
106 COMMINUTED FRACTURE 1 0.0030
107 FACIAL PARALYSIS 25 0.0029
108 HYPERALDOSTERONISM 1 0.0029
109 NEUROMUSCULAR TOXICITY 1 0.0028
110 PERIORBITAL SWELLING 16 0.0028
111 FACIAL DISCOMFORT 2 0.0028
112 INJECTION SITE SWELLING 213 0.0028
113 MILIA 1 0.0028
114 INJECTION SITE CELLULITIS 5 0.0027
115 FACIAL SPASM 3 0.0027
116 LIP DISORDER 5 0.0026
117 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 1 0.0026
118 DIAPHRAGMATIC DISORDER 2 0.0026
119 FAT TISSUE DECREASED 1 0.0026
120 DROPPED HEAD SYNDROME 1 0.0025
121 PERIORBITAL OEDEMA 13 0.0025
122 THERAPEUTIC RESPONSE DELAYED 7 0.0025
123 NEUTRALISING ANTIBODIES POSITIVE 1 0.0024
124 EYE CONTUSION 5 0.0024
125 ASTHENOPIA 13 0.0024
126 PERIORBITAL PAIN 2 0.0024
127 INJECTION SITE NODULE 26 0.0024
128 GASTROINTESTINAL HYPERMOTILITY 1 0.0023
129 FRONTOTEMPORAL DEMENTIA 1 0.0023
130 CUTANEOUS SARCOIDOSIS 1 0.0023
131 EYELID INFECTION 1 0.0023
132 NECK DEFORMITY 1 0.0023
133 OESOPHAGEAL INFECTION 1 0.0022
134 SALIVA ALTERED 2 0.0022
135 INJECTION SITE DRYNESS 2 0.0022
136 MAST CELL ACTIVATION SYNDROME 3 0.0021
137 MECHANICAL URTICARIA 1 0.0021
138 ECZEMA ASTEATOTIC 1 0.0021
139 LACRIMATION DECREASED 1 0.0021
140 SKIN TEXTURE ABNORMAL 2 0.0021
141 INFUSION SITE NODULE 2 0.0021
142 INJECTION SITE SCAB 2 0.0021
143 PATIENT DISSATISFACTION WITH TREATMENT 4 0.0021
144 ANAEMIA VITAMIN B12 DEFICIENCY 1 0.0020
145 NODULE 26 0.0020
146 SUSPECTED PRODUCT CONTAMINATION 2 0.0020
147 REDUCED FACIAL EXPRESSION 2 0.0020
148 INJECTION SITE NECROSIS 4 0.0020
149 EYE ALLERGY 3 0.0019
150 INJURY CORNEAL 1 0.0019
151 SINUSITIS BACTERIAL 2 0.0019
152 CEREBRAL ARTERY OCCLUSION 2 0.0019
153 INJECTION SITE INDURATION 24 0.0018
154 CLAUSTROPHOBIA 2 0.0018
155 INJECTION SITE ATROPHY 3 0.0018
156 THERAPY PARTIAL RESPONDER 28 0.0018
157 BONE FRAGMENTATION 1 0.0018
158 ELECTRIC SHOCK SENSATION 5 0.0018
159 MEDICAL DEVICE SITE PAIN 1 0.0018
160 APNOEIC ATTACK 1 0.0018
161 JOINT ANKYLOSIS 1 0.0018
162 INTENTION TREMOR 1 0.0018
163 SWELLING OF EYELID 11 0.0018
164 BLEPHAROSPASM 11 0.0017
165 CERVICAL SPINAL STENOSIS 3 0.0017
166 OPHTHALMIC HERPES SIMPLEX 1 0.0017
167 ENTERAL NUTRITION 1 0.0017
168 SPINAL CORD INJURY 3 0.0017
169 OSTEOGENESIS IMPERFECTA 1 0.0017
170 HYPOAESTHESIA EYE 1 0.0017
171 FACIAL PARESIS 6 0.0017
172 GASTROINTESTINAL BACTERIAL OVERGROWTH 1 0.0017
173 DEEP BRAIN STIMULATION 1 0.0017
174 EYELID OEDEMA 19 0.0016
175 LARYNGEAL DISCOMFORT 1 0.0016
176 FACIAL PAIN 14 0.0016
177 EXTREMITY CONTRACTURE 1 0.0016
178 CHALAZION 1 0.0016
179 CHORIORETINITIS 1 0.0016
180 ATROPHY 3 0.0015
181 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
182 BURNING SENSATION 104 0.0015
183 INJECTION SITE URTICARIA 36 0.0015
184 PARALYSIS 21 0.0015
185 DRUG INEFFECTIVE 1876 0.0014
186 MYCOBACTERIUM ABSCESSUS INFECTION 1 0.0014
187 TENSION HEADACHE 6 0.0014
188 OFF LABEL USE 1218 0.0014
189 LARYNGEAL DISORDER 1 0.0014
190 DYSLALIA 1 0.0014
191 APALLIC SYNDROME 1 0.0014
192 ACCOMMODATION DISORDER 1 0.0014
193 BRAIN CONTUSION 1 0.0014
194 DIET REFUSAL 1 0.0014
195 DARK CIRCLES UNDER EYES 2 0.0014
196 DYSPHAGIA 127 0.0013
197 CHOLANGITIS ACUTE 1 0.0013
198 BASOPHIL COUNT INCREASED 1 0.0013
199 INJECTION SITE PAPULE 6 0.0013
200 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
201 UNDERDOSE 94 0.0013
202 OPHTHALMOPLEGIA 2 0.0013
203 CSF PROTEIN INCREASED 1 0.0012
204 SWELLING 111 0.0012
205 INFECTED BITE 1 0.0012
206 APTYALISM 1 0.0012
207 VIITH NERVE PARALYSIS 4 0.0012
208 DIPLOPIA 30 0.0012
209 VASCULAR PSEUDOANEURYSM 2 0.0011
210 INFUSION SITE DISCHARGE 2 0.0011
211 DRUG RESISTANCE 29 0.0011
212 INJECTION SITE ERYTHEMA 140 0.0011
213 ANOGENITAL WARTS 1 0.0011
214 INJECTION SITE PAIN 343 0.0011
215 MUSCLE DISORDER 9 0.0011
216 OROPHARYNGEAL CANDIDIASIS 1 0.0011
217 MONOPARESIS 2 0.0011
218 OVERDOSE 237 0.0011
219 VITREOUS HAEMORRHAGE 3 0.0011
220 ABULIA 1 0.0011
221 PHARYNGEAL HYPOAESTHESIA 1 0.0011
222 ADVERSE FOOD REACTION 1 0.0011
223 RASH PAPULAR 24 0.0011
224 INJECTION SITE ULCER 1 0.0011
225 INTUSSUSCEPTION 1 0.0010
226 BLADDER CATHETERISATION 1 0.0010
227 STRABISMUS 3 0.0010
228 PYELONEPHRITIS ACUTE 2 0.0010
229 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
230 BLOOD IMMUNOGLOBULIN M DECREASED 1 0.0010
231 SUDDEN HEARING LOSS 2 0.0010
232 MUSCLE CONTRACTURE 2 0.0010
233 EYELID PAIN 2 0.0010
234 MASTICATION DISORDER 3 0.0010
235 BRAIN STEM INFARCTION 1 0.0010
236 DYSAESTHESIA 3 0.0010
237 NEUROGENIC BLADDER 2 0.0009
238 VASCULAR OCCLUSION 2 0.0009
239 INNER EAR DISORDER 1 0.0009
240 INJECTION SITE DISCHARGE 5 0.0009
241 MUSCLE TIGHTNESS 15 0.0009
242 HORDEOLUM 4 0.0009
243 INFUSION SITE MASS 1 0.0009
244 CERVICAL DYSPLASIA 2 0.0009
245 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
246 DEMENTIA WITH LEWY BODIES 1 0.0009
247 MACROCYTOSIS 1 0.0009
248 OPTIC NERVE INJURY 1 0.0009
249 HYPERREFLEXIA 3 0.0009
250 HYPORESPONSIVE TO STIMULI 1 0.0009
251 INJECTION SITE RASH 26 0.0008
252 EYE SWELLING 31 0.0008
253 SCLERODERMA 3 0.0008
254 EYELID IRRITATION 2 0.0008
255 PARANASAL SINUS DISCOMFORT 3 0.0008
256 HEAD DISCOMFORT 14 0.0008
257 PRODUCT USE IN UNAPPROVED INDICATION 195 0.0008
258 INCREASED BRONCHIAL SECRETION 2 0.0008
259 INFUSION SITE IRRITATION 1 0.0008
260 INFLUENZA LIKE ILLNESS 64 0.0008
261 DACRYOSTENOSIS ACQUIRED 1 0.0008
262 TRISMUS 4 0.0008
263 SKIN NECROSIS 4 0.0008
264 CARDIOPULMONARY FAILURE 3 0.0008
265 INJECTION SITE DISCOMFORT 8 0.0008
266 HYPOVITAMINOSIS 1 0.0008
267 HIRSUTISM 1 0.0008
268 NECK PAIN 42 0.0008
269 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
270 MACULAR HOLE 1 0.0007
271 ANAESTHETIC COMPLICATION 2 0.0007
272 CALCULUS BLADDER 1 0.0007
273 DRUG SPECIFIC ANTIBODY 1 0.0007
274 ASPIRATION 8 0.0007
275 HYPOAESTHESIA ORAL 11 0.0007
276 CORNEAL ABRASION 1 0.0007
277 MACULE 2 0.0007
278 OCULAR DISCOMFORT 8 0.0007
279 SENSATION OF FOREIGN BODY 6 0.0007
280 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
281 AUDITORY DISORDER 1 0.0007
282 INTENSIVE CARE 1 0.0007
283 INJECTION SITE SCAR 2 0.0007
284 EXERCISE TOLERANCE DECREASED 4 0.0007
285 PHARYNGEAL DISORDER 2 0.0007
286 MUSCLE TWITCHING 16 0.0007
287 MUTISM 1 0.0007
288 BEDRIDDEN 9 0.0007
289 SENSITIVE SKIN 5 0.0007
290 MUSCULAR WEAKNESS 77 0.0007
291 EXCESSIVE EYE BLINKING 1 0.0007
292 APRAXIA 1 0.0007
293 HYPOSMIA 1 0.0007
294 NEURITIS 1 0.0006
295 EYELIDS PRURITUS 2 0.0006
296 SKIN TIGHTNESS 3 0.0006
297 MUSCLE ATROPHY 8 0.0006
298 PHARYNGEAL PARAESTHESIA 1 0.0006
299 LOSS OF THERAPEUTIC RESPONSE 2 0.0006
300 INJECTION SITE PRURITUS 42 0.0006
301 SKIN EROSION 2 0.0006
302 GUILLAIN-BARRE SYNDROME 3 0.0006
303 CHOKING 12 0.0006
304 LEUKOCYTOCLASTIC VASCULITIS 1 0.0006
305 POSTURE ABNORMAL 2 0.0006
306 COSTOCHONDRITIS 1 0.0006
307 TENDON DISORDER 4 0.0006
308 PAPILLOMA VIRAL INFECTION 1 0.0006
309 INJECTION RELATED REACTION 1 0.0006
310 HYPOTONIA 6 0.0006
311 MITRAL VALVE PROLAPSE 1 0.0006
312 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
313 MYCOBACTERIAL INFECTION 1 0.0006
314 DROOLING 4 0.0006
315 DRUG EFFECT DECREASED 31 0.0006
316 HYPOPITUITARISM 1 0.0006
317 BURNS SECOND DEGREE 1 0.0006
318 MUSCLE SPASTICITY 7 0.0006
319 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
320 VISION BLURRED 78 0.0006
321 IMPAIRED WORK ABILITY 12 0.0006
322 PNEUMONIA ASPIRATION 14 0.0006
323 INJECTION SITE DISCOLOURATION 7 0.0006
324 FACIAL BONES FRACTURE 2 0.0006
325 OBSESSIVE THOUGHTS 1 0.0006
326 PANIC REACTION 4 0.0006
327 SWELLING FACE 36 0.0006
328 INJECTION SITE IRRITATION 7 0.0005
329 CAROTID ARTERY OCCLUSION 2 0.0005
330 JAW DISORDER 3 0.0005
331 FOOD INTOLERANCE 2 0.0005
332 SEBORRHOEA 2 0.0005
333 DEAFNESS UNILATERAL 3 0.0005
334 CHOKING SENSATION 3 0.0005
335 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
336 DRY EYE 27 0.0005
337 NERVE INJURY 6 0.0005
338 HEART RATE ABNORMAL 3 0.0005
339 HYPERACUSIS 2 0.0005
340 NASAL OBSTRUCTION 1 0.0005
341 PRODUCT STORAGE ISSUE 2 0.0005
342 IMPAIRED DRIVING ABILITY 6 0.0005
343 FACE INJURY 2 0.0005
344 MYELOPATHY 1 0.0005
345 PRODUCT PACKAGING ISSUE 5 0.0005
346 NEUROLOGICAL SYMPTOM 3 0.0005
347 MIGRAINE 50 0.0005
348 ADRENAL DISORDER 1 0.0005
349 MOTION SICKNESS 1 0.0005
350 APNOEA 4 0.0005
351 HYPOGEUSIA 1 0.0005
352 DIPLEGIA 1 0.0005
353 BLADDER DISORDER 5 0.0005
354 EXPOSURE VIA BREAST MILK 2 0.0005
355 MUSCLE RIGIDITY 6 0.0005
356 INJECTION SITE VESICLES 3 0.0005
357 FOAMING AT MOUTH 1 0.0005
358 MYASTHENIA GRAVIS 4 0.0005
359 INTENTIONAL PRODUCT USE ISSUE 43 0.0005
360 TRIGGER FINGER 2 0.0005
361 EAR DISCOMFORT 5 0.0005
362 ADVERSE EVENT 44 0.0005
363 HALLUCINATIONS, MIXED 2 0.0005
364 MEDICAL DEVICE PAIN 1 0.0005
365 HYPERPHOSPHATAEMIA 1 0.0005
366 EXOPHTHALMOS 1 0.0005
367 INFUSION SITE BRUISING 1 0.0005
368 LANGUAGE DISORDER 1 0.0005
369 HERPES SIMPLEX 3 0.0005
370 GASTRIC BYPASS 1 0.0005
371 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
372 EYE DISORDER 15 0.0005
373 DYSPHEMIA 2 0.0005
374 APPLICATION SITE PAIN 10 0.0005
375 ERYTHEMA 93 0.0005
376 SKIN MASS 3 0.0004
377 PARESIS 1 0.0004
378 BRAIN FOG 7 0.0004
379 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
380 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
381 PANIC ATTACK 16 0.0004
382 EYE MOVEMENT DISORDER 3 0.0004
383 PRODUCT PREPARATION ERROR 9 0.0004
384 PARAESTHESIA 68 0.0004
385 FLAT AFFECT 1 0.0004
386 LICHEN PLANUS 1 0.0004
387 LACRIMATION INCREASED 13 0.0004
388 PATELLA FRACTURE 1 0.0004
389 PAIN IN JAW 12 0.0004
390 MYOPIA 1 0.0004
391 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
392 DERMATITIS BULLOUS 3 0.0004
393 PRESCRIBED OVERDOSE 8 0.0004
394 DISCOMFORT 25 0.0004
395 VITREOUS FLOATERS 4 0.0004
396 HOSPICE CARE 4 0.0004
397 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
398 INFREQUENT BOWEL MOVEMENTS 1 0.0004
399 SPEECH DISORDER 21 0.0004
400 CONTUSION 38 0.0004
401 DRY MOUTH 32 0.0004
402 DRY THROAT 4 0.0004
403 DYSPHONIA 23 0.0004
404 ANGLE CLOSURE GLAUCOMA 1 0.0004
405 FEMORAL NECK FRACTURE 2 0.0004
406 SKIN DISORDER 13 0.0004
407 PHYSICAL DECONDITIONING 1 0.0004
408 DRUG ABUSE 32 0.0004
409 HYPERSENSITIVITY VASCULITIS 1 0.0004
410 INCONTINENCE 4 0.0004
411 ADVERSE REACTION 5 0.0004
412 LARYNGOSPASM 1 0.0004
413 EAR CONGESTION 1 0.0004
414 MIGRAINE WITH AURA 1 0.0004
415 PALLOR 10 0.0004
416 HYPERSENSITIVITY 68 0.0004
417 HYPERAESTHESIA 3 0.0004
418 INJECTION SITE REACTION 25 0.0004
419 THERAPEUTIC RESPONSE SHORTENED 12 0.0004
420 EOSINOPHILIC OESOPHAGITIS 1 0.0004
421 NECROSIS 2 0.0004
422 MULTIPLE USE OF SINGLE-USE PRODUCT 2 0.0004
423 DRUG TOLERANCE DECREASED 1 0.0004
424 FACE OEDEMA 6 0.0004
425 STATUS EPILEPTICUS 4 0.0004
426 JOINT LOCK 1 0.0004
427 MUSCULOSKELETAL DISCOMFORT 6 0.0003
428 EYELID MARGIN CRUSTING 1 0.0003
429 DYSPNOEA AT REST 1 0.0003
430 HYPERVENTILATION 2 0.0003
431 PRODUCT LABEL CONFUSION 2 0.0003
432 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
433 NEGATIVE THOUGHTS 1 0.0003
434 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
435 INFUSION SITE REACTION 1 0.0003
436 MYOSITIS 3 0.0003
437 HYPERCAPNIA 1 0.0003
438 PRESYNCOPE 8 0.0003
439 NEURALGIA 8 0.0003
440 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
441 TINNITUS 15 0.0003
442 DUODENITIS 1 0.0003
443 INJECTION SITE BRUISING 26 0.0003
444 FIBROSIS 1 0.0003
445 PIGMENTATION DISORDER 2 0.0003
446 LIMB DISCOMFORT 10 0.0003
447 SWOLLEN TONGUE 10 0.0003
448 NASAL DRYNESS 2 0.0003
449 EYE PAIN 18 0.0003
450 POISONING 4 0.0003
451 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
452 EXPOSURE TO TOXIC AGENT 1 0.0003
453 HEADACHE 195 0.0003
454 URTICARIA 52 0.0003
455 EAR PAIN 6 0.0003
456 LIVER ABSCESS 1 0.0003
457 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
458 AUTOIMMUNE DISORDER 3 0.0003
459 HYPOVENTILATION 1 0.0003
460 URINARY INCONTINENCE 9 0.0003
461 MATERNAL EXPOSURE DURING PREGNANCY 27 0.0003
462 LIP SWELLING 10 0.0003
463 LYME DISEASE 1 0.0003
464 APHASIA 9 0.0003
465 TOXIC SKIN ERUPTION 3 0.0003
466 WRONG PRODUCT ADMINISTERED 2 0.0003
467 THROAT TIGHTNESS 8 0.0003
468 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
469 PAIN 181 0.0003
470 HEPATIC CYST 1 0.0003
471 EPILEPSY 9 0.0003
472 HYPOAESTHESIA 44 0.0003
473 IMPAIRED GASTRIC EMPTYING 4 0.0003
474 DYSARTHRIA 11 0.0003
475 PERIPHERAL COLDNESS 4 0.0003
476 RESPIRATION ABNORMAL 2 0.0003
477 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
478 ENCEPHALITIS 2 0.0003
479 GRANULOMA 1 0.0003
480 HYPOPNOEA 1 0.0003
481 FORMICATION 2 0.0003
482 DEPRESSIVE SYMPTOM 1 0.0003
483 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
484 HAEMORRHAGIC DIATHESIS 1 0.0003
485 CONJUNCTIVAL HYPERAEMIA 1 0.0003
486 GASTROENTERITIS VIRAL 5 0.0003
487 TONGUE DISORDER 2 0.0003
488 INJECTION SITE HAEMATOMA 4 0.0003
489 DEVICE KINK 1 0.0003
490 ORAL DISORDER 2 0.0003
491 INFLAMMATION 14 0.0003
492 BLINDNESS TRANSIENT 2 0.0003
493 SUNBURN 2 0.0003
494 PHOTOPHOBIA 5 0.0003
495 PHARYNGEAL OEDEMA 4 0.0003
496 MUSCLE RUPTURE 1 0.0003
497 ATAXIA 3 0.0003
498 INTENTIONAL PRODUCT MISUSE 22 0.0003
499 GINGIVAL PAIN 2 0.0003
500 OBSTRUCTION 1 0.0003
501 BLEPHARITIS 1 0.0002
502 MOVEMENT DISORDER 8 0.0002
503 VERTIGO 15 0.0002
504 DYSKINESIA 10 0.0002
505 DECUBITUS ULCER 2 0.0002
506 ASPHYXIA 2 0.0002
507 INSOMNIA 65 0.0002
508 ANAPHYLACTOID REACTION 1 0.0002
509 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
510 GENERALISED OEDEMA 3 0.0002
511 CYST 3 0.0002
512 AORTIC DISSECTION 1 0.0002
513 DYSSTASIA 7 0.0002
514 SKIN DISCOLOURATION 11 0.0002
515 MUSCLE FATIGUE 1 0.0002
516 ABNORMAL SENSATION IN EYE 1 0.0002
517 MONOPLEGIA 1 0.0002
518 IMMOBILE 1 0.0002
519 MUSCLE SPASMS 42 0.0002
520 MUSCULOSKELETAL STIFFNESS 20 0.0002
521 ONYCHOMYCOSIS 1 0.0002
522 WRONG DRUG ADMINISTERED 2 0.0002
523 ILEUS PARALYTIC 1 0.0002
524 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
525 IRON DEFICIENCY 1 0.0002
526 OROPHARYNGEAL DISCOMFORT 2 0.0002
527 LIP DRY 2 0.0002
528 EAR DISORDER 1 0.0002
529 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
530 BRAIN NEOPLASM 2 0.0002
531 RETINAL DETACHMENT 2 0.0002
532 LOCALISED OEDEMA 1 0.0002
533 ORAL DISCOMFORT 3 0.0002
534 PRODUCT DISTRIBUTION ISSUE 2 0.0002
535 TACHYCARDIA 19 0.0002
536 SKIN REACTION 3 0.0002
537 EXPIRED PRODUCT ADMINISTERED 7 0.0002
538 MUSCULOSKELETAL DISORDER 4 0.0002
539 CARDIOGENIC SHOCK 3 0.0002
540 IMPAIRED QUALITY OF LIFE 3 0.0002
541 POST PROCEDURAL COMPLICATION 4 0.0002
542 FAECAL INCONTINENCE 1 0.0002
543 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 37 0.0002
544 INCORRECT DOSAGE ADMINISTERED 1 0.0002
545 PHARYNGEAL SWELLING 2 0.0002
546 BREATH SOUNDS ABNORMAL 1 0.0002
547 ANEURYSM 1 0.0002
548 THERAPY NON-RESPONDER 9 0.0002
549 SALIVARY HYPERSECRETION 2 0.0002
550 FLUID INTAKE REDUCED 1 0.0002
551 ERYSIPELAS 1 0.0002
552 NO ADVERSE EVENT 36 0.0002
553 PRODUCT PHYSICAL ISSUE 4 0.0002
554 PRODUCT ADMINISTRATION ERROR 4 0.0002
555 LYMPHADENOPATHY 7 0.0002
556 VISUAL IMPAIRMENT 24 0.0002
557 EYE DISCHARGE 2 0.0002
558 RESPIRATORY TRACT INFECTION 5 0.0002
559 LETHARGY 11 0.0002
560 PARTIAL SEIZURES 1 0.0002
561 MUSCULOSKELETAL PAIN 10 0.0002
562 CYANOSIS 3 0.0002
563 BLOOD LACTIC ACID INCREASED 1 0.0002
564 ANXIETY 54 0.0002
565 DIZZINESS 94 0.0002
566 PALPITATIONS 22 0.0002
567 SENSORY DISTURBANCE 3 0.0002
568 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
569 TREMOR 31 0.0002
570 OVERWEIGHT 1 0.0002
571 ERYTHEMA OF EYELID 1 0.0002
572 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
573 NONSPECIFIC REACTION 1 0.0002
574 INTESTINAL ISCHAEMIA 1 0.0002
575 TOOTH FRACTURE 2 0.0002
576 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
577 INJECTION SITE INJURY 1 0.0002
578 ON AND OFF PHENOMENON 1 0.0002
579 TOOTH DISORDER 4 0.0002
580 URINARY RETENTION 6 0.0002
581 ANGIOPATHY 1 0.0002
582 SNEEZING 4 0.0002
583 ACUTE PULMONARY OEDEMA 1 0.0002
584 BLOOD CALCIUM DECREASED 2 0.0002
585 CHOLECYSTITIS ACUTE 1 0.0002
586 SCAB 2 0.0002
587 DYSGEUSIA 13 0.0002
588 HYPERTONIA 1 0.0002
589 EYE IRRITATION 10 0.0002
590 HERPES VIRUS INFECTION 1 0.0002
591 MOUTH SWELLING 1 0.0002
592 ORTHOSTATIC HYPOTENSION 3 0.0002
593 LOCAL SWELLING 3 0.0002
594 VASCULITIS 2 0.0002
595 SPINAL PAIN 2 0.0002
596 HYPERCHLORHYDRIA 1 0.0002
597 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
598 OCULAR HYPERAEMIA 8 0.0002
599 CHOLECYSTITIS 2 0.0002
600 DISTURBANCE IN ATTENTION 9 0.0002
601 HEARING IMPAIRED 1 0.0002
602 SEIZURE 19 0.0002
603 SMALL INTESTINAL OBSTRUCTION 2 0.0002
604 LARYNGEAL OEDEMA 1 0.0002
605 OROPHARYNGEAL PAIN 15 0.0002
606 BALANCE DISORDER 14 0.0002
607 BACTERIAL INFECTION 3 0.0002
608 PRODUCT STORAGE ERROR 14 0.0002
609 SECRETION DISCHARGE 2 0.0002
610 CELLULITIS 8 0.0002
611 BRAIN OEDEMA 2 0.0002
612 PHOTOPSIA 1 0.0002
613 SLEEP APNOEA SYNDROME 3 0.0002
614 HYPOPHAGIA 4 0.0002
615 CHEST DISCOMFORT 16 0.0002
616 ACUTE RESPIRATORY FAILURE 3 0.0002
617 MYDRIASIS 2 0.0002
618 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
619 DYSTONIA 3 0.0002
620 RASH GENERALISED 4 0.0002
621 JOINT STIFFNESS 4 0.0002
622 DYSPNOEA 86 0.0002
623 IMMUNE SYSTEM DISORDER 2 0.0002
624 SINUS DISORDER 3 0.0002
625 RASH 66 0.0002
626 CORONAVIRUS INFECTION 1 0.0002
627 SYNCOPE 15 0.0001
628 EYE HAEMORRHAGE 2 0.0001
629 EYE PRURITUS 5 0.0001
630 SINUS CONGESTION 2 0.0001
631 ASTHENIA 55 0.0001
632 FEELING ABNORMAL 35 0.0001
633 INJECTION SITE WARMTH 3 0.0001
634 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
635 RESPIRATORY DISTRESS 4 0.0001
636 LYMPHOEDEMA 1 0.0001
637 FEELING COLD 4 0.0001
638 COORDINATION ABNORMAL 2 0.0001
639 APHONIA 2 0.0001
640 EXTRASYSTOLES 1 0.0001
641 DUODENAL ULCER 1 0.0001
642 HYPERHIDROSIS 18 0.0001
643 HERPES ZOSTER 8 0.0001
644 PARAESTHESIA ORAL 2 0.0001
645 HYPERTHYROIDISM 2 0.0001
646 HYPOKINESIA 2 0.0001
647 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
648 APATHY 2 0.0001
649 INTENTIONAL UNDERDOSE 1 0.0001
650 DYSURIA 5 0.0001
651 ARTHROPOD BITE 1 0.0001
652 RASH MACULO-PAPULAR 3 0.0001
653 FEELING DRUNK 1 0.0001
654 PRURITUS 51 0.0001
655 PAROSMIA 1 0.0001
656 BOWEL MOVEMENT IRREGULARITY 1 0.0001
657 FOOD ALLERGY 1 0.0001
658 CONCUSSION 1 0.0001
659 PELVIC FRACTURE 1 0.0001
660 NERVOUS SYSTEM DISORDER 4 0.0001
661 ANAPHYLACTIC REACTION 7 0.0001
662 DISORIENTATION 5 0.0001
663 NASAL DISCOMFORT 1 0.0001
664 ATRIAL FLUTTER 1 0.0001
665 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
666 BLOOD DISORDER 1 0.0001
667 HIP FRACTURE 4 0.0001
668 NIGHT SWEATS 4 0.0001
669 LOCALISED INFECTION 3 0.0001
670 MYALGIA 21 0.0001
671 HICCUPS 1 0.0001
672 HAIR DISORDER 1 0.0001
673 PHOTOSENSITIVITY REACTION 2 0.0001
674 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
675 MENSTRUAL DISORDER 1 0.0001
676 HEMIPLEGIA 1 0.0001
677 VIRAL INFECTION 4 0.0001
678 GAIT INABILITY 4 0.0001
679 CARDIO-RESPIRATORY ARREST 5 0.0001
680 SURGERY 7 0.0001
681 DRUG USE DISORDER 1 0.0001
682 HEMIPARESIS 2 0.0001
683 SINUSITIS 12 0.0001
684 SCAR 2 0.0001
685 UNRESPONSIVE TO STIMULI 3 0.0001
686 HAEMATOMA 3 0.0001
687 CARDIAC MURMUR 1 0.0001
688 HYSTERECTOMY 1 0.0001
689 CONDITION AGGRAVATED 35 0.0001
690 RASH MACULAR 4 0.0001
691 GROIN PAIN 1 0.0001
692 GRIP STRENGTH DECREASED 1 0.0001
693 ANGIOEDEMA 5 0.0001
694 EXPOSURE DURING PREGNANCY 7 0.0001
695 NAUSEA 89 0.0001
696 PRODUCT DOSE OMISSION ISSUE 33 0.0001
697 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
698 FEAR 3 0.0001
699 THROAT IRRITATION 5 0.0001
700 ANAL INCONTINENCE 1 0.0001
701 CHILLS 13 0.0001
702 OEDEMA 6 0.0001
703 GASTROINTESTINAL CARCINOMA 1 0.0001
704 GAIT DISTURBANCE 21 0.0001
705 SKIN IRRITATION 5 0.0001
706 INCREASED TENDENCY TO BRUISE 1 0.0001
707 NERVE COMPRESSION 1 0.0001
708 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
709 CONJUNCTIVITIS 2 0.0001
710 ERYTHEMA MULTIFORME 1 0.0001
711 COGNITIVE DISORDER 5 0.0001
712 DIARRHOEA HAEMORRHAGIC 1 0.0001
713 BLISTER 6 0.0001
714 HYPOCALCAEMIA 2 0.0001
715 EYE INFLAMMATION 1 0.0001
716 AFFECT LABILITY 1 0.0001
717 HERNIA 2 0.0001
718 LIGAMENT SPRAIN 1 0.0001
719 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
720 TOXICITY TO VARIOUS AGENTS 17 0.0001
721 BLOOD PRESSURE ABNORMAL 2 0.0001
722 RESPIRATORY DISORDER 3 0.0001
723 FATIGUE 78 0.0001
724 INJECTION SITE HAEMORRHAGE 8 0.0001
725 BLOOD POTASSIUM DECREASED 3 0.0001
726 HYPOTHERMIA 1 0.0001
727 FEEDING DISORDER 2 0.0001
728 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
729 FLUSHING 10 0.0001
730 DEATH 84 0.0001
731 FEMUR FRACTURE 3 0.0001
732 RESPIRATORY FAILURE 7 0.0001
733 PETECHIAE 1 0.0001
734 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
735 HALLUCINATION, VISUAL 2 0.0001
736 JOINT DISLOCATION 1 0.0001
737 EATING DISORDER 2 0.0001
738 POOR QUALITY SLEEP 2 0.0001
739 HALLUCINATION 7 0.0001
740 DEEP VEIN THROMBOSIS 6 0.0001
741 ACNE 7 0.0001
742 PRODUCT PRESCRIBING ISSUE 2 0.0001
743 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
744 DENTAL CARIES 1 0.0001
745 FOOT DEFORMITY 1 0.0001
746 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
747 HYPERTENSIVE CRISIS 1 0.0001
748 ORAL PAIN 2 0.0001
749 ADVERSE DRUG REACTION 8 0.0001
750 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
751 EYE INFECTION 1 0.0001
752 MITRAL VALVE INCOMPETENCE 1 0.0001
753 MYOCARDIAL ISCHAEMIA 1 0.0001
754 DERMATITIS CONTACT 1 0.0001
755 MICTURITION URGENCY 1 0.0001
756 MEMORY IMPAIRMENT 12 0.0001
757 NEPHROLITHIASIS 4 0.0001
758 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
759 MALAISE 38 0.0001
760 MADAROSIS 1 0.0001
761 CAESAREAN SECTION 1 0.0001
762 CARDIAC DISORDER 8 0.0001
763 ARRHYTHMIA 4 0.0001
764 WHEEZING 5 0.0001
765 BLOOD IRON DECREASED 1 0.0001
766 PRODUCT PRESCRIBING ERROR 2 0.0001
767 RASH ERYTHEMATOUS 4 0.0001
768 BLOOD PRESSURE FLUCTUATION 2 0.0001
769 DRUG EFFECT INCOMPLETE 3 0.0001
770 CRYING 3 0.0001
771 BURSITIS 1 0.0001
772 ADRENAL INSUFFICIENCY 1 0.0001
773 URINARY TRACT INFECTION 14 0.0001
774 COUGH 23 0.0001
775 ACCIDENTAL OVERDOSE 3 0.0001
776 RESTLESSNESS 3 0.0001
777 CEREBRAL INFARCTION 2 0.0001
778 ENCEPHALOPATHY 2 0.0001
779 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
780 FALL 27 0.0001
781 INJECTION SITE EXTRAVASATION 1 0.0001
782 CHEST PAIN 15 0.0001
783 CONFUSIONAL STATE 13 0.0001
784 ASTHMA 9 0.0001
785 DERMATITIS ALLERGIC 1 0.0001
786 WEIGHT DECREASED 22 0.0001
787 INTRAOCULAR PRESSURE INCREASED 1 0.0001
788 RHINORRHOEA 5 0.0001
789 HIATUS HERNIA 1 0.0001
790 DEAFNESS 2 0.0001
791 SEDATION 2 0.0001
792 ARTHRITIS 6 0.0001
793 BRADYCARDIA 4 0.0001
794 EAR INFECTION 2 0.0001
795 ABORTION SPONTANEOUS 3 0.0001
796 THROMBOSIS 6 0.0001
797 JOINT RANGE OF MOTION DECREASED 1 0.0001
798 SOMNOLENCE 15 0.0001
799 VOMITING 35 0.0001
800 RASH PRURITIC 4 0.0001
801 SKIN LESION 2 0.0001
802 CARDIAC ARREST 6 0.0001
803 PROCEDURAL PAIN 2 0.0001
804 BLOOD PRESSURE INCREASED 11 0.0001
805 DYSPEPSIA 7 0.0001
806 DEVICE OCCLUSION 1 0.0001
807 SLEEP DISORDER 5 0.0001
808 CEREBROVASCULAR ACCIDENT 12 0.0001
809 HEART RATE INCREASED 7 0.0001
810 INTENTIONAL DOSE OMISSION 2 0.0001
811 HYPOACUSIS 3 0.0001
812 MOBILITY DECREASED 5 0.0001
813 MYELODYSPLASTIC SYNDROME 1 0.0001
814 CONSTIPATION 15 0.0001
815 GASTROENTERITIS 1 0.0001
816 NASAL CONGESTION 4 0.0001
817 ILLNESS 7 0.0001
818 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
819 HAEMORRHAGE INTRACRANIAL 1 0.0001
820 EMOTIONAL DISTRESS 8 0.0001
821 OSTEOPENIA 1 0.0001
822 DEVICE FAILURE 1 0.0001
823 HIP ARTHROPLASTY 1 0.0001
824 FEELING HOT 4 0.0001
825 DRUG ADMINISTRATION ERROR 2 0.0001
826 MUSCULOSKELETAL CHEST PAIN 1 0.0001
827 ANKLE FRACTURE 1 0.0001
828 DECREASED APPETITE 15 0.0001
829 BACK PAIN 15 0.0001
830 BASAL CELL CARCINOMA 1 0.0001
831 PRODUCT USE ISSUE 12 0.0001
832 PYREXIA 22 0.0001
833 MULTIPLE SCLEROSIS 3 0.0001
834 COVID-19 11 0.0001
835 LOSS OF CONSCIOUSNESS 8 0.0001
836 INTENTIONAL OVERDOSE 4 0.0001
837 DEPRESSION 14 0.0001
838 METASTASES TO BONE 1 0.0001
839 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
840 THERAPY CESSATION 3 0.0001
841 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
842 GASTRIC DISORDER 2 0.0001
843 JOINT SWELLING 7 0.0001
844 NERVOUSNESS 3 0.0001
845 NEUROTOXICITY 1 0.0001
846 HEART RATE DECREASED 2 0.0001
847 LYMPHOCYTE COUNT DECREASED 1 0.0001
848 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
849 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
850 ISCHAEMIC STROKE 1 0.0001
851 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
852 C-REACTIVE PROTEIN INCREASED 2 0.0001
853 BONE DISORDER 1 0.0001
854 MEDICATION ERROR 3 0.0001
855 BREAST CANCER 5 0.0001
856 HEPATIC CIRRHOSIS 1 0.0001
857 BLOOD SODIUM DECREASED 1 0.0001
858 FRACTURE 1 0.0001
859 FOOT FRACTURE 1 0.0001
860 BLOOD URINE PRESENT 1 0.0001
861 LOWER LIMB FRACTURE 1 0.0001
862 GLAUCOMA 1 0.0001
863 ERUCTATION 1 0.0001
864 ORAL HERPES 1 0.0001
865 KIDNEY INFECTION 1 0.0001
866 ILL-DEFINED DISORDER 3 0.0000
867 BLINDNESS 2 0.0000
868 BODY TEMPERATURE INCREASED 1 0.0000
869 POLLAKIURIA 2 0.0000
870 ROAD TRAFFIC ACCIDENT 2 0.0000
871 DERMATITIS 1 0.0000
872 PAIN IN EXTREMITY 14 0.0000
873 SKIN EXFOLIATION 4 0.0000
874 IRRITABLE BOWEL SYNDROME 1 0.0000
875 PNEUMONIA 15 0.0000
876 AMNESIA 3 0.0000
877 MENTAL DISORDER 2 0.0000
878 ALOPECIA 9 0.0000
879 HOSPITALISATION 7 0.0000
880 INFUSION RELATED REACTION 3 0.0000
881 BLOOD PRESSURE DECREASED 3 0.0000
882 INFLUENZA 5 0.0000
883 COLITIS ULCERATIVE 2 0.0000
884 GLOSSODYNIA 1 0.0000
885 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
886 APPLICATION SITE PRURITUS 1 0.0000
887 ABDOMINAL PAIN UPPER 9 0.0000
888 SUICIDAL IDEATION 4 0.0000
889 DIARRHOEA 28 0.0000
890 ABDOMINAL PAIN 10 0.0000
891 HYPERTENSION 9 0.0000
892 PRODUCTIVE COUGH 2 0.0000
893 SKIN BURNING SENSATION 3 0.0000
894 MENTAL IMPAIRMENT 1 0.0000
895 HYPOGLYCAEMIA 2 0.0000
896 OEDEMA PERIPHERAL 5 0.0000
897 ABASIA 1 0.0000
898 AGEUSIA 1 0.0000
899 UNEVALUABLE EVENT 3 0.0000
900 FLUID RETENTION 2 0.0000
901 PERIPHERAL SWELLING 6 0.0000
902 ERECTILE DYSFUNCTION 1 0.0000
903 ANAPHYLACTIC SHOCK 1 0.0000
904 EXPOSURE VIA SKIN CONTACT 1 0.0000
905 ECZEMA 2 0.0000
906 ANHEDONIA 1 0.0000
907 GASTRITIS 1 0.0000
908 DEPRESSED MOOD 2 0.0000
909 DEHYDRATION 5 0.0000
910 DRUG DEPENDENCE 6 0.0000
911 JAUNDICE 1 0.0000
912 PAIN OF SKIN 1 0.0000
913 LIMB INJURY 1 0.0000
914 MOOD ALTERED 1 0.0000
915 TREATMENT FAILURE 3 0.0000
916 DIVERTICULITIS 1 0.0000
917 MENTAL STATUS CHANGES 1 0.0000
918 HAEMOPTYSIS 1 0.0000
919 DEMENTIA 1 0.0000
920 OXYGEN SATURATION DECREASED 2 0.0000
921 HYPONATRAEMIA 2 0.0000
922 FLATULENCE 2 0.0000
923 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
924 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
925 BONE PAIN 2 0.0000
926 ACUTE MYOCARDIAL INFARCTION 1 0.0000
927 LABORATORY TEST ABNORMAL 1 0.0000
928 DISEASE PROGRESSION 4 0.0000
929 HEAD INJURY 1 0.0000
930 PULMONARY EMBOLISM 3 0.0000
931 CYSTITIS 1 0.0000
932 MOOD SWINGS 1 0.0000
933 DRUG INTOLERANCE 3 0.0000
934 ATRIAL FIBRILLATION 3 0.0000
935 PRODUCT DOSE OMISSION 2 0.0000
936 CHOLELITHIASIS 1 0.0000
937 IMPAIRED HEALING 1 0.0000
938 DEVICE DIFFICULT TO USE 2 0.0000
939 FUNGAL INFECTION 1 0.0000
940 DRY SKIN 4 0.0000
941 ABDOMINAL DISCOMFORT 5 0.0000
942 ANGER 1 0.0000
943 PRODUCT QUALITY ISSUE 4 0.0000
944 NIGHTMARE 1 0.0000
945 ARTHRALGIA 12 0.0000
946 DELIRIUM 1 0.0000
947 ABDOMINAL DISTENSION 3 0.0000
948 HYPERKALAEMIA 1 0.0000
949 DEVICE MALFUNCTION 2 0.0000
950 HYPOXIA 1 0.0000
951 CEREBRAL HAEMORRHAGE 1 0.0000
952 AGITATION 2 0.0000
953 NASOPHARYNGITIS 5 0.0000
954 BRONCHITIS 2 0.0000
955 HEPATIC FUNCTION ABNORMAL 1 0.0000
956 EPISTAXIS 2 0.0000
957 DYSPNOEA EXERTIONAL 1 0.0000
958 COLITIS 1 0.0000
959 ABNORMAL BEHAVIOUR 1 0.0000
960 OSTEOPOROSIS 1 0.0000
961 DEVICE LEAKAGE 1 0.0000
962 DEVICE DISLOCATION 1 0.0000
963 MYOCARDIAL INFARCTION 4 0.0000
964 WEIGHT INCREASED 5 0.0000
965 GASTROINTESTINAL DISORDER 2 0.0000
966 DEVICE ISSUE 2 0.0000
967 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
968 NEUROPATHY PERIPHERAL 2 0.0000
969 BLOOD GLUCOSE DECREASED 1 0.0000
970 LUNG DISORDER 1 0.0000
971 HAEMORRHAGE 2 0.0000
972 HAEMATOCHEZIA 1 0.0000
973 ARTHROPATHY 1 0.0000
974 SEPSIS 2 0.0000
975 CATARACT 1 0.0000
976 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
977 HEPATIC ENZYME INCREASED 1 0.0000
978 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
979 HOT FLUSH 1 0.0000
980 INCORRECT DOSE ADMINISTERED 3 0.0000
981 DIABETES MELLITUS 1 0.0000
982 DRUG INTERACTION 2 0.0000
983 CARDIAC FAILURE 1 0.0000
984 DRUG WITHDRAWAL SYNDROME 1 0.0000
985 ANAEMIA 2 0.0000
986 HYPOTENSION 2 0.0000
987 HAEMOGLOBIN DECREASED 1 0.0000
988 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
989 INFECTION 1 0.0000
990 ACUTE KIDNEY INJURY 1 0.0000
991 DRUG DOSE OMISSION 1 0.0000